tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
CEL-SCI teams with Saudi Arabia pharmaceutical, healthcare company for Multikine
PremiumThe FlyCEL-SCI teams with Saudi Arabia pharmaceutical, healthcare company for Multikine
1M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
CEL-SCI 2M share Spot Secondary priced at $2.50
Premium
The Fly
CEL-SCI 2M share Spot Secondary priced at $2.50
3M ago
CEL-SCI publishes new data from Multikine study
PremiumThe FlyCEL-SCI publishes new data from Multikine study
5M ago
CEL-SCI announces pricing of $2.56M common stock offering
Premium
The Fly
CEL-SCI announces pricing of $2.56M common stock offering
5M ago
CEL-SCI announces neoadjuvant nivolumab plus chemotherapy study published
Premium
The Fly
CEL-SCI announces neoadjuvant nivolumab plus chemotherapy study published
5M ago
CEL-SCI provides rationale for use of Multikine in head, neck cancer study
PremiumThe FlyCEL-SCI provides rationale for use of Multikine in head, neck cancer study
8M ago
CEL-SCI, FDA agree on patient selection approach for Multikine study
Premium
The Fly
CEL-SCI, FDA agree on patient selection approach for Multikine study
9M ago
CEL-SCI files to sell 1M shares of common stock for holders
Premium
The Fly
CEL-SCI files to sell 1M shares of common stock for holders
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100